Anti-retroviral therapy trials are expected to begin in Denmark before the end of the year, with a drug that could prove to be a long-awaited cure for the AIDS virus.
The results of preliminary laboratory tests carried out by two teams of Australian scientists in collaboration with their colleagues from Denmark are encouraging about the hope of finding a cure.
An Australian study clearly shows that the Oncologic drug venetoclax has the ability to detect “cells” in the human body that are adversely affected by the virus.
Next year, in addition to Denmark, trials of the drug will also begin in Melbourne, Australia.
Meanwhile, pills with the trade name VENCLEXTA were originally developed to fight blood cancer.
It was approved in the United States in 2016 and since then, according to doctors, it has already helped thousands of cancer patients.
There are currently around 40 million people living with HIV in the world.
Examination and finally the use of drugs to reduce the severity of the disease makes it possible to prevent the spread of the HIV virus, which prevents the immediate damage to the victim’s immune system.
When a person uses drugs regularly, the victim also leaves them a danger to his loved ones – but he is completely safe.
